Media releases

We have expanded our priority focus areas to include unapproved peptide products, following increased detection of unlawful importation, supply and advertising, posing potential risks to consumer safety.

We have issued 27 infringement notices, totalling $101,412, to a NSW-based individual for the alleged unlawful supply of Melanotan II to Australian consumers in contravention of the Therapeutic Goods Act 1989.

We have led Australia's participation in INTERPOL's Operation Pangea XVIII, a coordinated global action targeting the illegal trade of illicit and counterfeit therapeutic goods.

We have published new guidance on Manufacturing, supplying and advertising compounded medicines lawfully, to support compliance with Australia’s regulatory requirements.

The Federal Court of Australia has ordered Key Promotional Products Pty Ltd to pay $1,750,000 for the unlawful import and supply of over 240,000 COVID-19 detection rapid antigen test kits. An individual was also ordered to pay $250,000.

We have issued 4 infringement notices totalling $79,200 to Switch Nutrition Pty Ltd (Switch Nutrition) for the alleged unlawful advertising of therapeutic goods.